Abstract 5499: Temozolomide (TMZ) cytotoxicity in human melanoma cell lines is enhanced by concomitant treatment with the histone deacetylase (HDAC) inhibitor vorinostat (SAHA) and PARP inhibitor MK-4827
Year: 2011
Type: conference-abstract
Source: Cancer Research
Authors: Hussein Tawbi, John M. Kirkwood, Ying-Chih Lin, Shama C. Buch, Yan Lin, Lyubov Kublo, Jan H. Beumer, Merrill J. Egorin, Edward Chu, Pamela Hershberger
Institutions: UPMC Hillman Cancer Center, University of Pittsburgh
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2004633003